Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-07-28 Jovan-Embiricos Morana Director Grant or award +684,622 $4.61 $3.2M 2,059,884
2022-07-28 Jovan-Embiricos Morana Director Grant or award +325,379 $4.61 $1.5M 668,072
2022-07-28 Jovan-Embiricos Morana Director Grant or award +1,626,898 $4.61 $7.5M 2,038,583
2022-07-28 Jovan-Embiricos Morana Director Grant or award +1,393,874 $4.61 $6.4M 4,193,874
2022-07-28 Jovan-Embiricos Morana Director Grant or award +867,678 $4.61 $4.0M 867,678
2022-07-28 Jovan-Embiricos Morana Director Grant or award +3,253,796 $4.61 $15.0M 16,674,766
2022-07-28 ElevateBio, LLC Director Grant or award +3,253,796 $4.61 $15.0M 16,674,766
2022-07-28 GADICKE ANSBERT Director Grant or award +3,253,796 $4.61 $15.0M 16,674,766
2022-07-21 Atillasoy Ercem See Remarks Sale −1,533 $5.38 $8K 133,467
2022-07-21 Hallal David Director Sale −4,227 $5.33 $23K 2,073,662
2022-07-20 Sinha Vikas See Remarks Sale −1,432 $5.21 $7K 938,224
2022-07-20 Atillasoy Ercem See Remarks Sale −563 $5.21 $3K 135,000
2022-07-20 VAN BEEK JEROEN B Chief Commercial Officer Sale −1,058 $5.21 $6K 401,953
2022-07-01 Leen Ann M. Chief Scientific Officer Grant or award +14,000 65,256
2022-07-01 Leen Ann M. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +26,000 392,344
2022-07-01 Hagen Brett R Chief Accounting Officer Grant or award +10,500 93,578
2022-07-01 Hagen Brett R Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +19,500 19,500
2022-01-18 Leen Ann M. Chief Scientific Officer Grant or award +23,256 51,256
2022-01-18 Leen Ann M. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +56,744 366,344

Page 13 of 13 · 259 trades